3 results match your criteria: "Jiaxing College School of Medicine[Affiliation]"
Int J Infect Dis
July 2024
Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Hangzhou 310009, China. Electronic address:
Background: The course of organ dysfunction (OD) in Corona Virus Disease 2019 (COVID-19) patients is unknown. Herein, we analyze the temporal patterns of OD in intensive care unit-admitted COVID-19 patients.
Methods: Sequential organ failure assessment scores were evaluated daily within 2 weeks of admission to determine the temporal trajectory of OD using group-based multitrajectory modeling (GBMTM).
Zhongguo Ying Yong Sheng Li Xue Za Zhi
August 2008
Department of Physiology, Jiaxing College School of Medicine, Jiaxing 314001, China.
Aim: To investigate the effect of three types of nitric oxide synthase inhibitors on the changes of hemodynamic parameters and thoracic aorta tension induced by septic shock in rats.
Methods: We used cecal ligation and puncture (CLP) method to establish septic shock in rats, and the three types of nitric oxide synthase inhibitors were injected after CLP. The carotid artery was cannulated and connected to a pressure transducer to determine mean arterial blood pressure (MABP).
Conf Proc IEEE Eng Med Biol Soc
September 2008
Zhejiang University School of Medicine, Hangzhou, China; Department of Physiology, Jiaxing College School of Medicine, Jiaxing, China.
The aim of the present study was to determine the possible mechanism by which rutin causes vasodilatation in isolated thoracic aorta rings from the rat. The effects of rutin on rings preconstricted with phenylephrine, with or without endothelium, were determined using an organ bath technique. The mechanism was explored by measuring the effects of the nitric oxide synthase inhibitor L-N(G)-nitroarginine methyl ester (L-NAME), the guanylyl cyclase inhibitor methylene blue, the cyclooxygenase inhibitor indomethacin, the ATP-sensitive Kchannel blocker glibenclamide and the beta-adrenoceptor antagonist propranolol.
View Article and Find Full Text PDF